ArticleBritish journal of cancer2017
Estimating the impact of a cancer diagnosis on life expectancy by socio-economic group for a range of cancer types in England.
Article in British journal of cancer, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
27 citing papers in PubMed, 64 citations in OpenAlex.
- Loss of life expectancy in patients with myeloproliferative neoplasms in Sweden.Haematologica · 2026Article
- Racial/ethnic and sex disparities in mortality among US cancer survivors.Journal of cancer research and clinical oncology · 2026Article
- Life expectancy of cancer patients in China.Military Medical Research · 2026Article
- Estimating the impact of cancer diagnosis on life expectancy by stage at diagnosis: population-based estimates for a range of cancer sites in England.BMJ oncology · 2026Article
- Loss in life expectancy after a colon cancer diagnosis by socioeconomic group: does the indicator of socioeconomic position matter?BMC public health · 2025Article
- Prevalence of multiple lung diseases among the people and associated with wealth status and behavior factors: a longitudinal study in West Bengal.Journal of health, population, and nutrition · 2025Article
- Global, regional, and national burden of high body-mass index-related cancers and associated preventable life expectancy loss from 1990 to 2021.Frontiers in nutrition · 2025Article
- Impact of cancer diagnosis on life expectancy by area-level socioeconomic groups in New South Wales, Australia: a population-based study.Cancer biology & medicine · 2024Article
- Impacts of socioeconomic and environmental factors on neoplasms incidence rates using machine learning and GIS: a cross-sectional study in Iran.Scientific reports · 2024Article
- Therapeutic Approaches to Increase the Survival Rate of Cancer Patients in the Younger and Older Population.Current aging science · 2024Review
- Use of Systemic Therapies for Treatment of Psoriasis in Patients with a History of Treated Solid Tumours: Inference-Based Guidance from a Multidisciplinary Expert Panel.Dermatology and therapy · 2023Article
- How do study design features and participant characteristics influence willingness to participate in clinical trials? Results from a choice experiment.BMC medical research methodology · 2022Article
- Heterogeneous trends of premature mortalities in Japan: joinpoint regression analysis of years of life lost from 2011 to 2019.Dialogues in health · 2022Article
- Socio-economic inequalities in cancer survival: how do they translate into Number of Life-Years Lost?British journal of cancer · 2022Article
- Assessing lead time bias due to mammography screening on estimates of loss in life expectancy.Breast cancer research : BCR · 2022Article
- Time Trends and Income Inequalities in Cancer Incidence and Cancer-Free Life Expectancy - a Cancer Site-Specific Analysis of German Health Insurance Data.Frontiers in oncology · 2022Article
- Article
- Follow-up practice and healthcare utilisation of colorectal cancer survivors.European journal of cancer care · 2021Article
- Systematic review of the association between socioeconomic status and bladder cancer survival with hospital type, comorbidities, and treatment delay as mediators.BJUI compass · 2021Review
- Understanding disparities in cancer prognosis: An extension of mediation analysis to the relative survival framework.Biometrical journal. Biometrische Zeitschrift · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 2 countries.
Funding
Abstract
backgroundDifferences in cancer survival exist across socio-economic groups for many cancer types. Standard metrics fail to show the overall impact for patients and the population.
methodsThe available data consist of a population of ∼2.5 million patients and include all patients recorded as being diagnosed with melanoma, prostate, bladder, breast, colon, rectum, lung, ovarian and stomach cancers in England between 1998 and 2013. We estimated the average loss in expectation of life per patient in years and the proportion of life lost for a range of cancer types, separately by deprivation group. In addition, estimates for the total number of years lost due to each cancer were also obtained.
resultsLung and stomach cancers result in the highest overall loss for males and females in all deprivation groups in terms of both absolute life years lost and loss as a proportion of expected life remaining. Female lung cancer patients in the least- and most-deprived group lose 14.4 and 13.8 years on average, respectively, that is translated as 86.1% and 87.3% of their average expected life years remaining. Melanoma, prostate and breast cancers have the lowest overall loss. On the basis of the number of patients diagnosed in 2013, lung cancer results in the most life years lost in total followed by breast cancer. Melanoma and bladder cancer account for the lowest total life years lost.
conclusionsThere are wide differences in the impact of cancer on life expectancy across deprivation groups, and for most cancers the most affluent lose less years.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.